These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
579 related articles for article (PubMed ID: 34103615)
1. Quinacrine directly dissociates amyloid plaques in the brain of 5XFAD transgenic mouse model of Alzheimer's disease. Park S; Kim HY; Oh HA; Shin J; Park IW; Yoon S; Woo DH; Kim Y Sci Rep; 2021 Jun; 11(1):12043. PubMed ID: 34103615 [TBL] [Abstract][Full Text] [Related]
11. The interaction of insoluble Amyloid-β with soluble Amyloid-β dimers decreases Amyloid-β plaque numbers. van Gerresheim EF; Herring A; Gremer L; Müller-Schiffmann A; Keyvani K; Korth C Neuropathol Appl Neurobiol; 2021 Aug; 47(5):603-610. PubMed ID: 33338256 [TBL] [Abstract][Full Text] [Related]
12. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library. Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663 [TBL] [Abstract][Full Text] [Related]
13. MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer's Disease. Jeong YO; Shin SJ; Park JY; Ku BK; Song JS; Kim JJ; Jeon SG; Lee SM; Moon M Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29912176 [TBL] [Abstract][Full Text] [Related]
14. Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level. Sadleir KR; Eimer WA; Cole SL; Vassar R Mol Neurodegener; 2015 Jan; 10():1. PubMed ID: 25567526 [TBL] [Abstract][Full Text] [Related]
15. The Anti-amyloid Compound DO1 Decreases Plaque Pathology and Neuroinflammation-Related Expression Changes in 5xFAD Transgenic Mice. Boeddrich A; Babila JT; Wiglenda T; Diez L; Jacob M; Nietfeld W; Huska MR; Haenig C; Groenke N; Buntru A; Blanc E; Meier JC; Vannoni E; Erck C; Friedrich B; Martens H; Neuendorf N; Schnoegl S; Wolfer DP; Loos M; Beule D; Andrade-Navarro MA; Wanker EE Cell Chem Biol; 2019 Jan; 26(1):109-120.e7. PubMed ID: 30472115 [TBL] [Abstract][Full Text] [Related]
16. Endogenous Apolipoprotein E (ApoE) Fragmentation Is Linked to Amyloid Pathology in Transgenic Mouse Models of Alzheimer's Disease. Saul A; Wirths O Mol Neurobiol; 2017 Jan; 54(1):319-327. PubMed ID: 26742512 [TBL] [Abstract][Full Text] [Related]
17. Orally Administered Benzofuran Derivative Disaggregated Aβ Plaques and Oligomers in the Brain of 5XFAD Alzheimer Transgenic Mouse. Kim D; Bae GH; Kim HY; Jeon H; Kim K; Shin J; Lee S; Hong S; Kim I; Kim Y ACS Chem Neurosci; 2021 Jan; 12(1):99-108. PubMed ID: 33332107 [TBL] [Abstract][Full Text] [Related]
18. Interactions between amyloid-β and hemoglobin: implications for amyloid plaque formation in Alzheimer's disease. Chuang JY; Lee CW; Shih YH; Yang T; Yu L; Kuo YM PLoS One; 2012; 7(3):e33120. PubMed ID: 22412990 [TBL] [Abstract][Full Text] [Related]
19. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model. Baik SH; Kang S; Son SM; Mook-Jung I Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617 [TBL] [Abstract][Full Text] [Related]
20. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. Oakley H; Cole SL; Logan S; Maus E; Shao P; Craft J; Guillozet-Bongaarts A; Ohno M; Disterhoft J; Van Eldik L; Berry R; Vassar R J Neurosci; 2006 Oct; 26(40):10129-40. PubMed ID: 17021169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]